The global market for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.

North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.

This report aims to provide a comprehensive presentation of the global market for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).

The Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Report

Report Metric	Details
Report Name	Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
Segment by Type	Paracetamol Ibuprofen Aspirin Naproxen Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Pfizer, Boehringer Ingelheim, Teva Pharmaceutical, Hospira, Lonza Group, Mylan, Aurobindo Pharma, Dr. Reddy's Laboratories, Actavis, Wuxi Apptec, Zhejiang NHU
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market report?

Ans: The main players in the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market are Novartis, Pfizer, Boehringer Ingelheim, Teva Pharmaceutical, Hospira, Lonza Group, Mylan, Aurobindo Pharma, Dr. Reddy's Laboratories, Actavis, Wuxi Apptec, Zhejiang NHU

What are the Application segmentation covered in the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market report?

Ans: The Applications covered in the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market report?

Ans: The Types covered in the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market report are Paracetamol, Ibuprofen, Aspirin, Naproxen, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Paracetamol

1.2.3 Ibuprofen

1.2.4 Aspirin

1.2.5 Naproxen

1.2.6 Others

1.3 Market by Application

1.3.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2020-2031)

2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Region

2.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Region (2020-2025)

2.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2026-2031)

2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Dynamics

2.3.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends

2.3.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers

2.3.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges

2.3.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue

3.1.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2020-2025)

3.1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2020-2025)

3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue

3.4 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio

3.4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2024

3.5 Global Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Head office and Area Served

3.6 Global Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Product and Application

3.7 Global Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Type

4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2020-2025)

4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2026-2031)

5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application

5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Application (2020-2025)

5.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2020-2031)

6.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2020-2025)

6.4 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2020-2031)

7.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2020-2025)

7.4 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2020-2031)

8.2 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2020-2025)

8.4 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2020-2031)

9.2 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2020-2025)

9.4 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2020-2031)

10.2 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2020-2025)

10.4 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.1.4 Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

11.1.5 Novartis Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.2.4 Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Boehringer Ingelheim

11.3.1 Boehringer Ingelheim Company Details

11.3.2 Boehringer Ingelheim Business Overview

11.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.3.4 Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

11.3.5 Boehringer Ingelheim Recent Development

11.4 Teva Pharmaceutical

11.4.1 Teva Pharmaceutical Company Details

11.4.2 Teva Pharmaceutical Business Overview

11.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.4.4 Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

11.4.5 Teva Pharmaceutical Recent Development

11.5 Hospira

11.5.1 Hospira Company Details

11.5.2 Hospira Business Overview

11.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.5.4 Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

11.5.5 Hospira Recent Development

11.6 Lonza Group

11.6.1 Lonza Group Company Details

11.6.2 Lonza Group Business Overview

11.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.6.4 Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

11.6.5 Lonza Group Recent Development

11.7 Mylan

11.7.1 Mylan Company Details

11.7.2 Mylan Business Overview

11.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.7.4 Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

11.7.5 Mylan Recent Development

11.8 Aurobindo Pharma

11.8.1 Aurobindo Pharma Company Details

11.8.2 Aurobindo Pharma Business Overview

11.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.8.4 Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

11.8.5 Aurobindo Pharma Recent Development

11.9 Dr. Reddy's Laboratories

11.9.1 Dr. Reddy's Laboratories Company Details

11.9.2 Dr. Reddy's Laboratories Business Overview

11.9.3 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.9.4 Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

11.9.5 Dr. Reddy's Laboratories Recent Development

11.10 Actavis

11.10.1 Actavis Company Details

11.10.2 Actavis Business Overview

11.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.10.4 Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

11.10.5 Actavis Recent Development

11.11 Wuxi Apptec

11.11.1 Wuxi Apptec Company Details

11.11.2 Wuxi Apptec Business Overview

11.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.11.4 Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

11.11.5 Wuxi Apptec Recent Development

11.12 Zhejiang NHU

11.12.1 Zhejiang NHU Company Details

11.12.2 Zhejiang NHU Business Overview

11.12.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.12.4 Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

11.12.5 Zhejiang NHU Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Dr. Reddy’s Laboratories

Actavis

WuXi AppTec

Zhejiang NHU

List of Tables

Table 1. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Paracetamol

Table 3. Key Players of Ibuprofen

Table 4. Key Players of Aspirin

Table 5. Key Players of Naproxen

Table 6. Key Players of Others

Table 7. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2020-2025)

Table 11. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2026-2031)

Table 13. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends

Table 14. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers

Table 15. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges

Table 16. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints

Table 17. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2020-2025)

Table 19. Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2024)

Table 20. Ranking of Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Headquarters and Area Served

Table 23. Global Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Product and Application

Table 24. Global Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2020-2025)

Table 28. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2026-2031)

Table 30. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2020-2025)

Table 32. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2026-2031)

Table 34. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2026-2031) & (US$ Million)

Table 49. Novartis Company Details

Table 50. Novartis Business Overview

Table 51. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 52. Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025) & (US$ Million)

Table 53. Novartis Recent Development

Table 54. Pfizer Company Details

Table 55. Pfizer Business Overview

Table 56. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 57. Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025) & (US$ Million)

Table 58. Pfizer Recent Development

Table 59. Boehringer Ingelheim Company Details

Table 60. Boehringer Ingelheim Business Overview

Table 61. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 62. Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025) & (US$ Million)

Table 63. Boehringer Ingelheim Recent Development

Table 64. Teva Pharmaceutical Company Details

Table 65. Teva Pharmaceutical Business Overview

Table 66. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 67. Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025) & (US$ Million)

Table 68. Teva Pharmaceutical Recent Development

Table 69. Hospira Company Details

Table 70. Hospira Business Overview

Table 71. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 72. Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025) & (US$ Million)

Table 73. Hospira Recent Development

Table 74. Lonza Group Company Details

Table 75. Lonza Group Business Overview

Table 76. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 77. Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025) & (US$ Million)

Table 78. Lonza Group Recent Development

Table 79. Mylan Company Details

Table 80. Mylan Business Overview

Table 81. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 82. Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025) & (US$ Million)

Table 83. Mylan Recent Development

Table 84. Aurobindo Pharma Company Details

Table 85. Aurobindo Pharma Business Overview

Table 86. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 87. Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025) & (US$ Million)

Table 88. Aurobindo Pharma Recent Development

Table 89. Dr. Reddy's Laboratories Company Details

Table 90. Dr. Reddy's Laboratories Business Overview

Table 91. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 92. Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025) & (US$ Million)

Table 93. Dr. Reddy's Laboratories Recent Development

Table 94. Actavis Company Details

Table 95. Actavis Business Overview

Table 96. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 97. Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025) & (US$ Million)

Table 98. Actavis Recent Development

Table 99. Wuxi Apptec Company Details

Table 100. Wuxi Apptec Business Overview

Table 101. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 102. Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025) & (US$ Million)

Table 103. Wuxi Apptec Recent Development

Table 104. Zhejiang NHU Company Details

Table 105. Zhejiang NHU Business Overview

Table 106. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 107. Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025) & (US$ Million)

Table 108. Zhejiang NHU Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

Table 112. Authors List of This Report

List of Figures

Figure 1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Picture

Figure 2. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2024 VS 2031

Figure 4. Paracetamol Features

Figure 5. Ibuprofen Features

Figure 6. Aspirin Features

Figure 7. Naproxen Features

Figure 8. Others Features

Figure 9. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2024 VS 2031

Figure 11. Hospital Pharmacies Case Studies

Figure 12. Retail Pharmacies Case Studies

Figure 13. Online Pharmacies Case Studies

Figure 14. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered

Figure 15. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region: 2024 VS 2031

Figure 18. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2024

Figure 19. Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2024

Figure 21. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2020-2031)

Figure 23. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2020-2031)

Figure 27. Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2020-2031)

Figure 35. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2020-2031)

Figure 43. Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2020-2031)

Figure 47. Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Novartis Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

Figure 51. Pfizer Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

Figure 52. Boehringer Ingelheim Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

Figure 53. Teva Pharmaceutical Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

Figure 54. Hospira Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

Figure 55. Lonza Group Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

Figure 56. Mylan Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

Figure 57. Aurobindo Pharma Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

Figure 58. Dr. Reddy's Laboratories Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

Figure 59. Actavis Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

Figure 60. Wuxi Apptec Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

Figure 61. Zhejiang NHU Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Non Steroidal Anti Inflammatory Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025

Global Pets NSAIDs Market Research Report 2025

Global Pet NSAIDs Market Research Report 2025

Global Cyclooxygenase 2 Inhibitor Market Research Report 2024

Cox 2 Inhibitors Market

Global Anti inflammatory Drugs for Dental Market Research Report 2024

Analgesic and Anti inflammatory API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Advil Market Research Report 2024

Global Cyclooxygenase 2 Inhibitor COVID 19 Market Research Report 2024

Global Nonsteroidal Anti inflammatory APIs Market Research Report 2024

Global Tenoxicam Market Research Report 2024

Global NSAID API Market Research Report 2024

Global Anti inflammatory Agents Market Research Report 2024

Non steroidal Anti inflammatory Drugs NSAID Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Loxoprofen Market Research Report 2024

Global Celecoxib Market Insights Forecast to 2030

Global Carprofen Market Research Report 2025

Global Meloxicam Drugs Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions